In our study, the results showed that Rh4 could target SIX1 to inhibit the TGF-β/Smad2/3 signaling pathway and effectively suppressed EMT metastasis in GC cells according to the wound healing assay, transwell assay, proteome sequencing, and Western blot. This evidence concerns the gene SIX1 and gastric cancer.